Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |